SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +7.1% ·
aandelenstroom +30.0% ·
netto nieuwe posities +6.7%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 5.86K | $247,641 | n/a | n/a |
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | n/a | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | n/a |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | n/a | n/a |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | n/a | 12.73M | $106.08M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.28M | +7.3% | $401.23M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | Marshall Wace ✦ | 2.95M | +1283.7% | $127.30M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | State Street Global Advisors ✦ (passief) | 2.64M | n/a | $114.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passief) | 1.99M | +15.1% | $86.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.77M | +14.7% | $76.53M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 1.73M | +763.8% | $74.58M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 7 | Citadel Advisors ✦ | 1.72M | +119.3% | $74.25M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 1.59M | Nieuw | $68.93M | 0.1% | New | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 721.96K | Nieuw | $31.20M | 0.0% | New | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 666.88K | +240.6% | $28.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 554.74K | -24.4% | $23.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 397.55K | -35.8% | $17.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Millennium Management ✦ | 145.70K | -78.3% | $6.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 45.70K | -80.4% | $1.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 8.08K | -91.8% | $349,088 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $68.93M | 0.1% |
| Capital World Investors | $31.20M | 0.0% |
Verlaten
| Point72 Asset Management | $229,477 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 274 houders, 132.63M aandelen, $6.20B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.